Nathi Magubane for Penn Today: “Research on seminoma to develop better treatments has been impeded by the lack of relevant mouse models and the scarcity of seminoma samples. Additionally, the tumor itself is complex, with varied cell types and a significant presence of immune cells, making it hard to analyze in bulk.
“‘These obstacles hinder comprehensively understanding seminoma’s genetic and molecular underpinnings,’ says Kotaro Sasaki, a physician scientist at the University of Pennsylvania’s School of Veterinary Medicine who is leading the charge on researching the biology of urogenital cancers at the molecular level.”